about
Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case reportRefined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalAdvances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.White blood cell counts: reference methodology.Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentCutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.Performance of BinaxNOW for diagnosis of malaria in a U.S. hospital.Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group.CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.Variability of PD-L1 expression in mastocytosisPD-L1 Expression in Mastocytosis.Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group studyA phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosisCurrent Aspects of Clonal Hematopoiesis: Implications for Clinical DiagnosisPatient advocacy and its importance to laboratory medicine practiceEvolution of the International Journal of Laboratory Hematology
P50
Q21198810-75D0CC38-017F-4B03-AED2-38E58A49E3CDQ34137971-EE06903F-5300-4BFB-B26D-37E4E3509C15Q34552564-A6A7C1A5-D5C7-4BF6-BCE1-5FD1AE069316Q35560088-1B67170A-0C02-43AB-A901-689DE6326970Q35789965-7414AD47-EA0A-4E60-A720-51AD815869ADQ35848377-0110ACEB-8390-41DA-B686-60CC6AEE7E92Q36730397-F41011DD-F01B-4454-8734-0B1E06240D1AQ37151676-F78CF94F-A67C-4611-B752-740FB22D0EDAQ38609927-E40ACC9D-EE2E-47B1-BE4D-45C5F481211AQ39089887-D21B92D1-82E4-4B0B-BBA3-4D8DD3090E0BQ40837658-9254CBD1-AE6E-48DF-9B3E-67CBE55F9ECEQ41230339-0851D904-E2A0-42F5-9CBF-24D943645A73Q42281134-1F119FB5-10AD-475E-893A-3473D6D76299Q46039976-50476292-AA18-4DBD-B2D6-6FBCA285408BQ46270625-F6843D15-36B3-463C-BF5C-8C0628047080Q46413457-8C711C27-CF19-442E-AC6A-A20CA97D36EAQ46825476-EA91415D-5C95-47C6-BBDE-62501BE2E34DQ47930594-FEDC4447-1B67-49F0-8AB3-21FD6E0B3AD5Q48508435-853D7BAE-04BC-40DD-A1E2-2D88690ABDE0Q49820472-68ACC114-8CF0-4920-B903-2CDD97186AF7Q50484927-3C32C13A-CD6E-43F5-A145-EC95E6D36157Q54284130-00A308AA-F6FC-4AB6-B87E-6D1564B1DE97Q64046290-368CD080-53CB-4824-A9DC-0067BE71D85EQ64966503-42CC5B45-88C2-4876-9295-46E2FA312600Q91980430-A3B22F80-C015-48CB-A6BD-2D0BFBA0DB05Q92214144-448F01ED-9180-4BA7-AEB2-10FC77F5B15DQ93035603-DA65689A-868F-4C72-8DC5-CB8B75677425Q96434620-60EF2553-4485-4152-BB9E-4C2F5BAF2CFDQ96434641-56E8A2E0-1F7E-402B-9936-CAC34EF2B81A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tracy I George
@ast
Tracy I George
@en
Tracy I George
@es
Tracy I George
@nl
type
label
Tracy I George
@ast
Tracy I George
@en
Tracy I George
@es
Tracy I George
@nl
prefLabel
Tracy I George
@ast
Tracy I George
@en
Tracy I George
@es
Tracy I George
@nl
P108
P106
P31
P496
0000-0001-5478-7847